Search Results

Filter
  • 1-10 of  66,350 results for ""ALTEPLASE""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Endovascular thrombectomy with or without intravenous alteplase in large-core ischemic stroke: a systematic review and meta-analysis.

  • Authors : Wang Z; Department of Neurology, The First Affiliated Hospital of Soochow University, No.899 Pinghai Road, Gusu District, Suzhou, 215031, Jiangsu Province, China. .; Ji K

Subjects: Endovascular Procedures*/Endovascular Procedures*/Endovascular Procedures*/methods ; Fibrinolytic Agents*/Fibrinolytic Agents*/Fibrinolytic Agents*/administration & dosage ; Ischemic Stroke*/Ischemic Stroke*/Ischemic Stroke*/therapy

  • Source: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2024 Nov; Vol. 45 (11), pp. 5129-5140. Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100959175 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Analysis of Clinical Characteristics and Influencing Factors of Early Neurological Deterioration in Patients With Mild Stroke by Intravenous Alteplase Therapy.

  • Authors : Mao XL; Department of Brain Center, Wenzhou Central Hospital, Dingli Clinical Institute of Wenzhou Medical University, Wenzhou, Zhejiang, China.; He SS

Subjects: Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/administration & dosage ; Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/adverse effects ; Fibrinolytic Agents*/Fibrinolytic Agents*/Fibrinolytic Agents*/administration & dosage

  • Source: The neurologist [Neurologist] 2024 Sep 01; Vol. 29 (5), pp. 275-279. Date of Electronic Publication: 2024 Sep 01.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9503763 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Mortality Outcomes with Tenecteplase Versus Alteplase in the Treatment of Massive Pulmonary Embolism.

  • Authors : Murphy LR; Department of Emergency Medicine, University of Texas Medical Branch at Galveston, Galveston, Texas. Electronic address: .; Singer A

Subjects: Tenecteplase*/Tenecteplase*/Tenecteplase*/therapeutic use ; Pulmonary Embolism*/Pulmonary Embolism*/Pulmonary Embolism*/drug therapy ; Pulmonary Embolism*/Pulmonary Embolism*/Pulmonary Embolism*/mortality

  • Source: The Journal of emergency medicine [J Emerg Med] 2024 Nov; Vol. 67 (5), pp. e432-e441. Date of Electronic Publication: 2024 Aug 03.Publisher: Elsevier Country of Publication: United States NLM ID: 8412174 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Early recanalization after tenecteplase versus alteplase: Experience in a large stroke network.

  • Authors : Karamchandani RR; Department of Neurology, Neurosciences Institute, Atrium Health, 1000 Blythe Blvd, Charlotte, NC, 28203, United States. Electronic address: .; Asimos AW

Subjects: Fibrinolytic Agents*/Fibrinolytic Agents*/Fibrinolytic Agents*/adverse effects ; Fibrinolytic Agents*/Fibrinolytic Agents*/Fibrinolytic Agents*/administration & dosage ; Tenecteplase*/Tenecteplase*/Tenecteplase*/adverse effects

  • Source: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2024 Nov; Vol. 33 (11), pp. 107931. Date of Electronic Publisher: Saunders Country of Publication: United States NLM ID: 9111633 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Efficacy and Safety of Intravenous Tenecteplase Versus Alteplase in Treating Acute Ischemic Stroke With Diabetes and Admission Hyperglycemia.

  • Authors : Liu H; Department of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China.; Department of Neurology and Clinical Research Center of Neurological Disease the Second Affiliated Hospital of Soochow University Suzhou China.

Subjects: Tenecteplase*/Tenecteplase*/Tenecteplase*/administration & dosage ; Tenecteplase*/Tenecteplase*/Tenecteplase*/adverse effects ; Ischemic Stroke*/Ischemic Stroke*/Ischemic Stroke*/drug therapy

  • Source: Journal of the American Heart Association [J Am Heart Assoc] 2024 Oct 15; Vol. 13 (20), pp. e036393. Date of Electronic Publication: 2024 Oct 11.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A retrospective study to evaluate the safety and efficacy of intrapleural alteplase in pediatric empyema.

Subjects: Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/therapeutic use ; Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/administration & dosage ; Fibrinolytic Agents*/Fibrinolytic Agents*/Fibrinolytic Agents*/administration & dosage

  • Source: Przeglad epidemiologiczny [Przegl Epidemiol] 2024 Sep 18; Vol. 78 (2), pp. 145-149. Date of Electronic Publication: 2024 Jun 07.Publisher: Narodowy Instytut Zdrowia Publicznego--Państwowy Zakład Higieny Country of Publication: Poland NLM ID: 0413725 Publication Model:

Record details

×
Academic Journal

Baseline neurological deficit and argatroban plus alteplase in acute ischemic stroke: A post hoc analysis of ARAIS trial.

  • Authors : Cui Y; Department of Neurology, General Hospital of Northern Theater Command, No.83 Wenhua Road, Shenhe District, Shenyang, 110016, China.; Zhou ZH

Subjects: Pipecolic Acids*/Pipecolic Acids*/Pipecolic Acids*/administration & dosage ; Pipecolic Acids*/Pipecolic Acids*/Pipecolic Acids*/therapeutic use ; Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/therapeutic use

  • Source: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2024 Sep; Vol. 21 (5), pp. e00382. Date of Electronic Publication: Publisher: Springer Country of Publication: United States NLM ID: 101290381 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Consent-Related Outcomes in the Alteplase Compared to Tenecteplase Trial.

  • Authors : Shamy MC; From the Department of Medicine (M.C.S., D.D.), University of Ottawa, Ontario; The Ottawa Hospital (M.C.S., D.D.), Ontario

Subjects: Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/therapeutic use ; Informed Consent* ; Tenecteplase*/Tenecteplase*/Tenecteplase*/therapeutic use

  • Source: Neurology [Neurology] 2024 Nov 26; Vol. 103 (10), pp. e209974. Date of Electronic Publication: 2024 Nov 07.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

The Time Has Come. The Time Is Now. IV Alteplase, Will You Please Go Now?

  • Authors : Ranta A; From the Department of Medicine (A.R.), University of Otago-Wellington; and Department of Neurology (A.R.), Wellington Hospital, Wellington, New Zealand.

Subjects: Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/therapeutic use ; Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/administration & dosage ; Fibrinolytic Agents*/Fibrinolytic Agents*/Fibrinolytic Agents*/therapeutic use

  • Source: Neurology [Neurology] 2024 Nov 12; Vol. 103 (9), pp. e209961. Date of Electronic Publication: 2024 Oct 16.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Tenecteplase vs Alteplase in Acute Ischemic Stroke Within 4.5 Hours: A Systematic Review and Meta-Analysis of Randomized Trials.

  • Authors : Palaiodimou L; From the Second Department of Neurology (L.P., A.T., A. Safouris, G. Tsivgoulis), 'Attikon' University Hospital, School of Medicine, National and Kapodistrian University of Athens, Greece; Department of Medicine (Neurology) (A.H.K.), McMaster University/Population Health Research Institute, Hamilton, Ontario, Canada

Subjects: Tenecteplase*/Tenecteplase*/Tenecteplase*/therapeutic use ; Tenecteplase*/Tenecteplase*/Tenecteplase*/administration & dosage ; Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/therapeutic use

  • Source: Neurology [Neurology] 2024 Nov 12; Vol. 103 (9), pp. e209903. Date of Electronic Publication: 2024 Oct 16.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  66,350 results for ""ALTEPLASE""